Costs & hospitals · patient guide

West China Hospital ENT: Hearing, Rhinology and Head-Neck Teams

West China Hospital's ENT department traces its origin to Chengdu Cunren Hospital in 1894 and organises clinical work into four groups: ear, hearing and speech; nose and allergy; throat; and head and neck. For an overseas patient, the practical question is which group fits the main problem, what records let that team assess it, and what the hospital must confirm before any visit.

Go to the practical guidance ↓
Illustrative image: A patient discusses medical documents with a healthcare professional in a clinic setting.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What the department is and how its work is divided

The department describes itself as a national clinical key specialty and as an ear, nose and throat clinical drug-trial base, with roles in endoscopic training and postdoctoral work. Those labels describe institutional standing and training activity. They do not tell an individual patient which clinic will see them or what treatment will be offered.

For planning, the useful detail is the four-part division: an ear, hearing and speech group; a nose and allergy group; a throat group; and a head and neck group. The department also describes combining multidisciplinary discussion of complex cases with research and teaching. A patient with one dominant problem, such as hearing loss, nasal obstruction or a neck mass, can use that division to frame a referral question rather than sending an undifferentiated request.

Its history begins with Chengdu Cunren Hospital in 1894. The modern department combines specialist clinical work with research and education, but the four groups have different focuses. Hearing rehabilitation, nasal and allergy work, voice disorders and head-neck tumor reconstruction are not interchangeable requests. Identifying the clinical question first makes the department's organization useful to someone considering an assessment.

Ear, hearing and speech: assessment before rehabilitation

The ear, hearing and speech program, described on a page dated 28 June 2024, covers hearing assessment, hearing and speech rehabilitation, genetic counselling for deafness and vestibular disorders. Its clinical scope also includes middle- and inner-ear work, Eustachian tube problems, facial nerve conditions and selected lateral skull-base work.

Cochlear and bone-conduction implants are included in the program's stated scope. They describe areas of clinical work, not a decision that an individual should receive an implant. An enquiry can ask how the team would review an existing hearing assessment, which question a further assessment would address and how any proposed rehabilitation would be discussed with the patient or family.

The program also describes collaboration with big-data, frontier-medicine and rare-disease research. For an unusual or previously investigated hearing problem, explain what diagnosis has already been considered and what remains unresolved. Ask which existing reports the team would want to see and whether the next step would involve the ear/hearing group or another specialty. That is different from ordering tests solely because they appear in a department description.

Nose, sinus and allergy: separating structural and allergic problems

The nose and allergy program page, dated 28 June 2024, describes nasal and sinus work alongside selected endoscopic skull-base procedures, including repair of cerebrospinal fluid leaks and work on recurrent nasopharyngeal tumour. The allergy centre's stated scope covers respiratory, drug and food allergy.

The nasal/sinus direction and the allergy center are related but distinct. A patient can state whether the established question concerns a structural condition, an allergy assessment or an earlier procedure. Ask which group would review it, what existing information should be supplied and what the assessment is intended to clarify. The program description does not determine a test or treatment for an individual.

The official program page also records Sichuan Medical Science and Technology Progress recognitions for basic and clinical rhinology research. This provides an academic context for the group alongside its clinical scope. The recognitions concern research activity; they do not identify a preferred procedure or predict a patient's response. For a new enquiry, the more specific issue is which part of the nasal or allergy problem needs another opinion.

Throat, voice and sleep: what the program covers

The throat and voice program page, dated 1 June 2024, lists sleep and snoring concerns, voice disorders, minimally invasive laryngeal tumour work, paediatric ENT and laryngotracheal stenosis. It also describes voice rehabilitation, various reconstructive techniques, and collaboration through multidisciplinary and clinical research.

An enquiry about voice, sleep or a previous laryngeal procedure should identify the established diagnosis and the decision still to be made. Ask which part of the throat program would assess the records and whether the question concerns diagnosis, rehabilitation or a proposed intervention. The team's response should clarify what can be assessed from the information already available and what would need a consultation.

The program's range is useful precisely because voice rehabilitation, airway reconstruction and pediatric ENT are different clinical directions. A person seeking an opinion on a prior plan can explain that plan and ask how the relevant team would review it. The department's listing of several techniques is not a reason to choose one before discussing the individual case.

Head and neck tumours and the multidisciplinary route

The head and neck program page, dated 23 July 2024, describes clinical work on laryngeal, hypopharyngeal, oropharyngeal, thyroid and salivary tumours, plus skull-base disease, with reconstructive flaps for tissue defects. It states that multidisciplinary discussion includes radiation oncology, pathology, biotherapy and thyroid surgery.

For a newly diagnosed or previously treated tumor, an enquiry can distinguish the question about tumor management from the question about reconstruction. Ask which disciplines would contribute to the review, which existing reports should be supplied and how the opinion would be communicated. The named program describes a collaborative structure rather than a promise that every case will follow the same pathway.

The reconstructive focus gives this group a different emphasis from a general ENT assessment. It is reasonable to ask how the team would consider the relationship between the tumor assessment and a possible tissue-defect reconstruction. The specific operation and the clinician responsible would need to be confirmed through the individual clinical assessment, not inferred from a program title.

Research that shapes the questions patients can ask

Two documented research strands show how laboratory and clinical work connect in this department. Neither is a treatment offer.

A hospital report dated 14 March 2023 describes a paper in Bioactive Materials on a self-fusing injectable hydrogel for glottic insufficiency. Yang Hui, described as a clinical professor, and Xie Huiqi, described as a researcher, are co-corresponding authors, with Zou Chenyu and Hu Juanjuan as first authors. The work examined material mechanics, extracellular matrix and vocal fold function in a rabbit model. It is preclinical animal research, not an approved human therapy, and it supports no claim about human voice outcomes.

A separate hospital report describes an eLife mechanistic multiomics study involving the teams of Zhao Yu, Ren Jianjun, Chen Fei and Yu Haopeng. The study used single-cell and spatial profiling to examine proliferative exhausted CD8 T cells, HPV status and the head and neck squamous cancer microenvironment. It is an association and mechanistic study. It does not establish a validated treatment, a routine biomarker or a prospective clinical benefit.

Honours, historical ranking and the questions to settle first

The department placed eighth in the Fudan 2023 national specialty reputation list. This is a historical departmental reference, not a ranking of its ear, nose, throat or head-neck groups. The research examples above provide more specific information about the team's interests and named academic contributors; they do not establish who would personally assess a new patient.

For an overseas patient, the practical decisions are narrower than the institutional record. Which of the four groups fits the main problem? What has already been tested, and can the reports be shared in a form the team can read? Does the hospital require original pathology material or its own imaging before a multidisciplinary discussion? What does the hospital's written plan include, and which parts are arranged through the hospital rather than an outside coordinator?

ChinaSpecialistCare can help organise an ENT enquiry, prepare records and coordinate visit arrangements after hospital acceptance. We are independent of the hospital and cannot guarantee a named specialist, procedure or outcome. A brief initial enquiry is free and does not require purchasing an optional proxy consultation.

Ear, nose and throat care

Sources & scope of this guide

References and official service information relevant to this guide.

  1. procedures
  2. Ear, nose and throat care
  3. Fudan 2023 historical national specialty reputation list
  4. West China Hospital official ENT department overview
  5. Official ENT head and neck program July2024
  6. Official nose and allergy program June2024
  7. Official ear-hearing and speech program June2024
  8. Official throat and voice program June2024
  9. Official Yang Hui and Xie Huiqi vocal-fold biomaterial study March2023
  10. Official Zhao Yu team head-neck tumor immune-microenvironment research

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.